Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 19 11 2019
accepted: 28 03 2020
revised: 03 03 2020
pubmed: 24 4 2020
medline: 29 6 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

The association of hidradenitis suppurativa with other skin diseases has not yet been investigated in larger studies based on dermatological exams. The objectives of this study are to determine the prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population. Between 2014 and 2017, 20,112 people in 343 German companies were examined for the presence of clinical features of hidradenitis suppurativa within the framework of a cross-sectional epidemiological study based on whole-body examinations. In addition, all cutaneous comorbidities were recorded. Point prevalence was calculated and the differences between individuals with and without hidradenitis suppurativa were determined by bivariate analysis. All statistical procedures were performed using SPSS 23.0 for Windows. Of 20,112 people examined, mean age was 43.6 ± 10.5 years; 52.3% were male. In total, n = 57 people (0.3%) with hidradenitis suppurativa were identified; 61.4% (n = 35) being male. In addition, non-inflammatory hidradenitis suppurativa-related lesions were found in 674 other individuals. In a bivariate comparison, patients with hidradenitis suppurativa showed significantly more frequently the following cutaneous comorbidities: acne vulgaris, psoriasis, seborrhoeic dermatitis, excoriations, and folliculitis. We determined a point prevalence of hidradenitis suppurativa of 0.3%. Since we have examined the working population, the healthy worker effect, which could have led to underestimation of prevalence, cannot be ruled out. The point prevalence of 0.3% for employed people in Germany and a prevalence of 3.0% for inflammatory and non-inflammatory hidradenitis suppurativa-related lesions show that hidradenitis suppurativa is an important disease for the whole health system.

Identifiants

pubmed: 32322958
doi: 10.1007/s00403-020-02065-2
pii: 10.1007/s00403-020-02065-2
pmc: PMC7864810
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

95-99

Références

Dermatology. 2017;233(6):456-461
pubmed: 29495009
Int J Dermatol. 2019 Oct;58(10):1112-1117
pubmed: 31148159
J Am Acad Dermatol. 2016 Oct;75(4):755-759.e1
pubmed: 27453539
J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44
pubmed: 25640693
J Am Acad Dermatol. 2019 Feb;80(2):551-554.e1
pubmed: 30554892
J Dermatol. 2018 Dec;45(12):1389-1395
pubmed: 30294846
J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):191-4
pubmed: 8708018
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1784-1790
pubmed: 29761904
J Am Acad Dermatol. 2008 Oct;59(4):596-601
pubmed: 18674845
Br J Dermatol. 2019 Apr;180(4):774-781
pubmed: 29999187
Br J Dermatol. 2018 Jan;178(1):e17-e18
pubmed: 28626985
J Dermatol. 2015 Jul;42(7):747-9
pubmed: 25898994
Br J Dermatol. 2019 Oct;181(4):866-869
pubmed: 30980721
J Am Acad Dermatol. 2018 Nov 28;:
pubmed: 30502412
J Am Acad Dermatol. 2013 Mar;68(3):412-9
pubmed: 22921795
JAMA Dermatol. 2019 Jun 5;:
pubmed: 31166590
JAMA Dermatol. 2019 Jul 10;:
pubmed: 31290938
Dermatology. 2016;232(3):344-52
pubmed: 27011206
J Am Acad Dermatol. 2017 Dec;77(6):1047-1052.e2
pubmed: 28989106
Br J Dermatol. 2017 Apr;176(4):1083-1085
pubmed: 27480611
J Invest Dermatol. 2018 Jun;138(6):1288-1292
pubmed: 29378201
J Eur Acad Dermatol Venereol. 2019 Oct;33(10):1941-1946
pubmed: 31132177
Curr Pain Headache Rep. 2017 Nov 1;21(12):49
pubmed: 29094219
PLoS One. 2018 Jul 24;13(7):e0200683
pubmed: 30040827
Br J Dermatol. 2015 Dec;173(6):1546-9
pubmed: 26198191

Auteurs

Natalia Kirsten (N)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany. n.kirsten@uke.de.

Nicole Zander (N)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.

Matthias Augustin (M)

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH